Eterna Therapeutics Inc. (NASDAQ: ERNA)
$2.08
-0.0100 ( -0.48% ) 1.1K
Eterna Therapeutics Inc is a biopharmaceuticals company. The company develops transformational new medicines using various cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. With its strategic partners, the group is developing nucleic acid and cell therapies that can significantly improve the health outcomes of patients with high unmet medical needs.
Market Data
Open
$2.08
Previous close
$2.09
Volume
1.1K
Market cap
$11.25M
Day range
$1.98 - $2.11
52 week range
$0.84 - $2.96
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Aug 10, 2023 |
8-k | 8K-related | 31 | Aug 02, 2023 |
8-k | 8K-related | 16 | Jul 18, 2023 |
4 | Insider transactions | 1 | Jul 18, 2023 |
4 | Insider transactions | 1 | Jul 18, 2023 |
4 | Insider transactions | 1 | Jul 18, 2023 |
8-k | 8K-related | 13 | Jul 13, 2023 |
3 | Insider transactions | 2 | Jul 11, 2023 |
3 | Insider transactions | 2 | Jul 11, 2023 |
8-k | 8K-related | 12 | Jul 11, 2023 |